Insider Michael Hardesty plans 716-share sale in NOC (NYSE: NOC)

Rhea-AI Filing Summary

Northrop Grumman insider Michael A. Hardesty filed a notice to sell up to 716 shares of common stock. The shares have an aggregate market value of $501,609.04, with an approximate sale date of February 17, 2026 on the NYSE through Fidelity Brokerage Services LLC.

The securities were acquired on February 16, 2023 via restricted stock vesting as compensation from the issuer. The notice states that 141,921,621 shares of common stock were outstanding. It also reports that Hardesty sold 784 common shares on February 13, 2026 for gross proceeds of $550,410.63. By signing, he represents that he is not aware of any undisclosed material adverse information about the issuer.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	716	501609.04	141921621	02/17/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/16/2023	Restricted Stock Vesting	Issuer			716	02/16/2023	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Michael A. Hardesty 2980 Fairview Park Drive Falls Church VA 22042	Common	02/13/2026	784	550410.63

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What insider transaction is disclosed for Northrop Grumman (NOC)?

Michael A. Hardesty filed a Rule 144 notice to sell up to 716 Northrop Grumman common shares. These shares have an aggregate market value of $501,609.04 and are expected to be sold on the NYSE through Fidelity Brokerage Services LLC around February 17, 2026.

How many Northrop Grumman (NOC) shares does the Rule 144 notice cover and what is their value?

The notice covers up to 716 Northrop Grumman common shares with an aggregate market value of $501,609.04. The planned sale is through Fidelity Brokerage Services LLC on the NYSE, with an approximate sale date of February 17, 2026, under Rule 144 resale provisions.

When and how were the Northrop Grumman (NOC) shares being sold under Rule 144 acquired?

The 716 Northrop Grumman common shares were acquired on February 16, 2023 through restricted stock vesting. The acquisition is described as compensation from the issuer, with the full amount of these securities acquired and paid on that same date.

What prior sales by Michael A. Hardesty in Northrop Grumman (NOC) stock are disclosed?

The disclosure lists a prior sale of 784 Northrop Grumman common shares by Michael A. Hardesty on February 13, 2026. Those shares generated gross proceeds of $550,410.63, and this transaction is reported as part of securities sold during the past three months.

How many Northrop Grumman (NOC) shares were outstanding in this Rule 144 notice?

The notice states that 141,921,621 shares of Northrop Grumman common stock were outstanding. This figure provides context for the planned Rule 144 sale of 716 shares and the previously sold 784 shares disclosed in the same document.

What representation does Michael A. Hardesty make about information on Northrop Grumman (NOC)?

By signing the notice, Michael A. Hardesty represents that he does not know any material adverse information about Northrop Grumman’s current or prospective operations that has not been publicly disclosed, consistent with the requirements for sales made under Rule 144.